Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
TBE Meningococcal Disease Influenza Smallpox

  Meningococcal Disease

1. Ramsay M, Collins M, Rush M, Kaczmarski EB.
The epidemiology of meningococcal disease in England and Wales., 1996 and 1997.
Eurosurveillance 1997;2:74-6

2. Kaczmarski EB.
Meningococcal disease in Engalng and Wales: 1995.
Commun Dis Rep CDR Rev 1997; 7:R55-9

3. The Merck Manual
17th Edition, CNS Infections Acute Bacterial Meningitis. pp1431-7
Kirsch EA, Barton RP, Ktichen L, Giroir BP.
Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.
Pediatr. Infect. Dis. J. 15: 967-979, 1996

4. Apicella MA
Neisseria meningitidis.
In Mandell GL, Nennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases (4th ed). Vol. 2. New York, Churchill Livingstone Inc, 1995, pp 1896-1909

5. Meningococcal Disease
Chapter 23 In: 'Immunisation against infectious disease' (1996 edn) Replacement Chapter Published by the Department of Health, 18 October 1999

 » Printversion

  » find


Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
» read more

Baxter receives preparedness contract from Austrian Ministry of Health for Pandemic Influenza Vaccine
» read more

Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
» read more

Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,